These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 25544546)
1. Resolution of severe cardiomyopathy in infantile Pompe disease. Parent JJ; Schamberger M Cardiol Young; 2015 Jan; 25(1):146-8. PubMed ID: 25544546 [TBL] [Abstract][Full Text] [Related]
2. Cardiac response to enzyme replacement therapy in infantile Pompe disease with severe hypertrophic cardiomyopathy. Avula S; Nguyen TM; Marble M; Lilje C Echocardiography; 2017 Apr; 34(4):621-624. PubMed ID: 28266734 [TBL] [Abstract][Full Text] [Related]
3. When should we start enzyme replacement therapy for infantile Pompe disease with severe cardiomyopathy? Bonilla-Palomas JL; Gámez-López AL; Tejero-Hernández MA; Tejero-Mateo I; López-López J Rev Esp Cardiol (Engl Ed); 2012 Jan; 65(1):100-2. PubMed ID: 21715078 [No Abstract] [Full Text] [Related]
4. Left ventricular geometry, global function, and dyssynchrony in infants and children with pompe cardiomyopathy undergoing enzyme replacement therapy. Chen CA; Chien YH; Hwu WL; Lee NC; Wang JK; Chen LR; Lu CW; Lin MT; Chiu SN; Chiu HH; Wu MH J Card Fail; 2011 Nov; 17(11):930-6. PubMed ID: 22041330 [TBL] [Abstract][Full Text] [Related]
5. Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease. Levine JC; Kishnani PS; Chen YT; Herlong JR; Li JS Pediatr Cardiol; 2008 Nov; 29(6):1033-42. PubMed ID: 18661169 [TBL] [Abstract][Full Text] [Related]
6. Apical Hypertrophic Cardiomyopathy in an Infant: First Presentation of Pompe's Disease. Patra S; Subramaniun A; Mahimaiha J; Sastry UM; Nanjappa MC World J Pediatr Congenit Heart Surg; 2014 Jul; 5(3):491-3. PubMed ID: 24958062 [TBL] [Abstract][Full Text] [Related]
7. Infantile-onset pompe disease: a tale of two cases. Tolani D; Bansal N; Sehgal S Cardiol Young; 2020 Feb; 30(2):275-277. PubMed ID: 31983366 [TBL] [Abstract][Full Text] [Related]
8. Enzyme replacement therapy in an infant with Pompe's disease with severe cardiomyopathy. Tanzer F; Buyukkayhan D; Cansu Mutlu E; Kalender Korkmaz F J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1159-62. PubMed ID: 20333876 [TBL] [Abstract][Full Text] [Related]
9. Infantile-onset Pompe disease with neonatal debut: A case report and literature review. Martínez M; Romero MG; Guereta LG; Cabrera M; Regojo RM; Albajara L; Couce ML; Pipaon MS Medicine (Baltimore); 2017 Dec; 96(51):e9186. PubMed ID: 29390460 [TBL] [Abstract][Full Text] [Related]
10. Occurrence of nutritional hypocalcaemic rickets-related dilated cardiomyopathy in a child with concomitant rickets and infantile-onset Pompe disease. Yeşilbaş O; Epçaçan S Cardiol Young; 2019 Mar; 29(3):425-427. PubMed ID: 30678746 [TBL] [Abstract][Full Text] [Related]
11. An interesting case of infant sudden death: severe hypertrophic cardiomyopathy in Pompe's disease. Metzl JD; Elias ER; Berul CI Pacing Clin Electrophysiol; 1999 May; 22(5):821-2. PubMed ID: 10353146 [TBL] [Abstract][Full Text] [Related]
12. [Enzyme replacement therapy in a boy with infantile Pompe disease: cardiac follow-up]. Bonnefoy R; Labarthe F; Paoli F; Chantreuil J; Barthez MA; Froissart R; Poinsot J; Chantepie A Arch Pediatr; 2008 Dec; 15(12):1760-4. PubMed ID: 18995995 [TBL] [Abstract][Full Text] [Related]
13. Infantile-onset Pompe disease: a diagnosis not to miss. Dixon CA; Anderson JB; Ruddy RM; Cripe LH Pediatr Emerg Care; 2010 Apr; 26(4):293-5. PubMed ID: 20386415 [TBL] [Abstract][Full Text] [Related]
14. New insights into therapeutic options for Pompe disease. Richard E; Douillard-Guilloux G; Caillaud C IUBMB Life; 2011 Nov; 63(11):979-86. PubMed ID: 22002928 [TBL] [Abstract][Full Text] [Related]
15. Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings. Teng YT; Su WJ; Hou JW; Huang SF Chang Gung Med J; 2004 May; 27(5):379-84. PubMed ID: 15366815 [TBL] [Abstract][Full Text] [Related]
17. Enzyme replacement therapy for infantile Pompe disease during the critical period and identification of a novel mutation. But WM; Lee SH; Chan AO; Lau GT Hong Kong Med J; 2009 Dec; 15(6):474-7. PubMed ID: 19966354 [TBL] [Abstract][Full Text] [Related]
18. Development of obstruction to ventricular outflow and impairment of inflow in glycogen storage disease of the heart: serial echocardiographic studies from birth to death at 6 months. Seifert BL; Snyder MS; Klein AA; O'Loughlin JE; Magid MS; Engle MA Am Heart J; 1992 Jan; 123(1):239-42. PubMed ID: 1729839 [No Abstract] [Full Text] [Related]
19. Spontaneous regression of hypertrophic cardiomyopathy in an infant with Pompe's disease. Spada M; Garelli D; Riggi C; Pagliardini V; Lualdi S; Filocamo M; Porta F Mol Genet Metab; 2012 Dec; 107(4):763. PubMed ID: 23088900 [No Abstract] [Full Text] [Related]
20. Glycogen storage disease type IIa. Gharpure V; Raghavan K; Mehta M; Kalgutkar A Indian J Pediatr; 1996; 63(2):259-62. PubMed ID: 10829999 [No Abstract] [Full Text] [Related] [Next] [New Search]